|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 31/122 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/14 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A23L 33/10 | (2016.01) | ||
| C07C 39/08 | (2006.01) |
| (11) | Number of the document | 3827815 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20216131.1 |
| Date of filing the European patent application | 2009-09-08 | |
| (97) | Date of publication of the European application | 2021-06-02 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
| (46) | Date of publication of the claims translation | 2023-10-10 |
| (30) | Number | Date | Country code |
| 191696 P | 2008-09-10 | US |
| (72) |
MILLER, Guy. M , US
KHEIFETS, Viktoria , US
|
| (73) |
PTC Therapeutics, Inc. ,
100 Corporate Court,
Middlesex Business Center, South Plainfield, NJ 07080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais |
| TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-09-08 |